Uber Technologies, filed a motion in federal court to dismiss an antitrust lawsuit filed against it, for failure to state claims.
Defense counsel’s response stated the plaintiff, the Philadelphia Taxi Association (PTA), was “unhappy with market forces” and “have sued Uber in the hopes that a lawsuit can insulate them from the competition that has resulted from Uber’s entry into Philadelphia.”
However, defense counsel added Uber’s entry into the local market “has enhanced competition, benefiting consumers by increasing output, choice and innovation, which is precisely what the antitrust laws are designed to protect.”
Uber’s attorneys argued their increased competition had not caused the plaintiffs harm, and is not evidence of a monopoly.
“Plaintiffs have not suffered harm that the antitrust laws are designed to prevent. Indeed, plaintiffs allege that Uber increased output, which is antithetical to any claim of antitrust injury,” the defense motion read.
Moreover, the defense believed the plaintiffs’ tortious interference claim failed because “they have not alleged with specificity the ‘contractual relations’ with which Uber allegedly interfered”, and that they similarly failed to argue Uber’s alleged conduct was done to harm the plaintiffs, as oppose to further its own legitimate business interests.
Full Content: Penn Record
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas